News
Crossed
Your contact person

Jan Phillip Denkers
PR & Communications Manager
T +49.40.593 62 61-23
E-Mail

Filter reset
The facility employs J.POD® technology that uses autonomous clean rooms to run small, highly intensified production processes, thereby reducing the cost of biologics manufacturing. (Picture: ©Benjamin Benschneider)

Biotech & Pharma

Just - Evotec Biologics opens J.POD® 1 US

Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing facility (J.POD® 1 US) in Redmond, Washington. The innovative cGMP biomanufacturing …